Ingrid Skop, M.D., FACOG

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove the in-person dispensing requirement for mifepristone.

This new peer-reviewed study from CLI scholars examined the associations between prior pregnancy loss and the risk of severe maternal morbidity at the time of a first subsequent live birth.

Some have raised concerns that limitations on mifepristone will harm women who need access to the drug for non-abortion indications. However, data is limited that mifepristone can always replace other medications already used for these indications, and even when mifepristone may be effective in such cases, reinstating the in-person dispensing requirement need not impact its use.

There are humane medical interventions that aim for both mother and her unborn child to live when possible and do not inflict direct violence on the unborn child.

This paper examines claims that pro-life laws in effect post-Dobbs would increase maternal mortality rates.

This paper explores the risks associated with drug-induced abortion using misoprostol alone.

The claim that later drug-induced abortions are “safe and effective” is false, with studies documenting higher rates of complications following later drug-induced abortions compared to the first trimester. Due to the FDA's removal of the in-person dispensing requirement, these later drug-induced abortions often occur outside of a medical facility, increasing the odds that complications will be more severe if emergency care is not readily available.

Iowa’s abortion law allows for timely and necessary care for pregnant women in a medical emergency, and permits physicians to use their reasonable medical judgment to determine if a medical emergency exists. Additionally, Iowa has an ecosystem of support for moms and babies.

CLI Vice President and Director of Medical Affairs Ingrid Skop, M.D., gave a testimony before the South Dakota Senate State Affairs Committee on March 2. The Senate State Affairs Committee considered House Bill amendment 1257D, clarifying the definition of what is not considered an abortion (i.e., treatment of ectopic pregnancy or miscarriage).